NDATOPICALLOTION
Approved
Nov 2015
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Clinical Trials (2)
Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
Started Nov 2020
Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis
Started Apr 2016
Loss of Exclusivity
LOE Date
Jun 19, 2033
88 months away
Patent Expiry
Jun 19, 2033
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8962028 | Jun 19, 2033 | Product | U-1775 |
Company
Lacer
Spain - Barcelona